Currently, TG Therapeutics Inc’s (TGTX) stock is trading at $27.55, marking a fall of -3.00% from last night’s close. At this price, the stock is -40.73% below its 52-week high of $46.48 and 47.71% above its 52-week low of $18.65.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, TGTX’s SMA-200 is $34.14.
As well, it is important to consider TGTX stock ratios such as price-to-sales, which is currently 9.63.TGTX’s price to book ratio for the most recent quarter was 18.36, resulting in an 15.68 price to cash per share for the period.
How does TG Therapeutics Inc (TGTX) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
TG Therapeutics Inc (TGTX): Earnings History
If we examine TG Therapeutics Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of $0.17, beating the consensus of $0.29. In other words, it topped the consensus by -$0.12, resulting in a -40.85% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of $0.17 in contrast with the Outlook of $0.29. That was a difference of -$0.12 and a surprise of -40.85%.
TG Therapeutics Inc (NASDAQ: TGTX) Ownership Details
I will give a breakdown of the key shareholders in TG Therapeutics Inc (TGTX). Recent figures show that the company’s insiders hold 9.74% of shares. A total of 479 institutional investors hold shares in the company, making 63.27% of its stock and 70.10% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Blackrock Inc. holding total of 21.49 shares that make 13.54% of the company’s total number of shares and are currently priced at 595.84 million.
The securities firm Vanguard Group Inc holds 15.6 shares of TGTX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 9.83% , and the holding percentage of shares is valued at 432.56 million.
An overview of TG Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests TG Therapeutics Inc (TGTX) traded 2,209,175 shares per day, with a moving average of $35.81 and price change of -10.28. With the moving average of $36.37 and a price change of -6.93, about 1,888,580 shares changed hands on average over the past 50 days. Finally, TGTX’s 100-day average volume is 2,380,701 shares, alongside a moving average of $37.37 and a price change of -9.42.
